S&P 500 7,356.16 â–ŧ 9.30 (-0.13%) DOW 51,833.81 ▲ 166.97 (+0.32%) NASDAQ 25,470.02 â–ŧ 117.02 (-0.46%) US Markets Closed â€ĸ 08:38 PM ET

HQL

Abrdn Life Sciences Investors

Price Chart
Latest Quote

$18.89

+0.26 (+1.40%)
Current Price
Previous Close $18.63
Open $18.76
Day High $19.00
Day Low $18.71
Volume 161,949
Fetched: 2026-06-25T00:38:00
Stock Information
Quarterly Dividend / Yield $2.04 / 10.95%
Shares Outstanding 30.41M
Quarterly Dividend Yield 10.95%
Quarterly Dividend $2.04
Cash Equivalents $852K
Revenue $1.11M
Net Income $198.17M
Sector Financial Services
Industry Asset Management
Market Cap $574.41M
P/E Ratio 2.81
EPS (TTM) $6.73
Exchange NYQ
📊 Comprehensive Analysis
Company Data
Enterprise Value$565.65M
Sales$1.11M
Income$198.17M
Book/sh$17.35
Cash/sh$0.03
Financial Ratios
Quick Ratio1.55
Current Ratio1.61
Returns & Margins
ROA-0.61%
ROE41.42%
Gross Margin100.00%
Operating Margin-516.53%
Profit Margin17856.98%
Ownership
Insider Ownership0.00%
Institutional Ownership27.86%
Insider & Institutional transactions data not available
Valuation Ratios
P/S517.60
P/B1.09
Analyst Data
Recommendationnone
Technical Indicators
SMA20$17.44
SMA50$17.31
SMA200$15.90
RSI76.20
ATR0.4650
Short Ratio0.24
Volatility0.73
Rel Volume1.41
Performance History
Week+10.21%
Month+9.89%
Quarter+20.57%
6 Months+19.34%
YTD+20.19%
Year+71.72%
3 Years+99.34%
5 Years+57.05%
10 Years+197.74%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-24 $18.89 161,949
2026-06-23 $18.63 140,400
2026-06-22 $18.34 166,000
2026-06-18 $17.96 120,500
2026-06-17 $17.86 167,700
2026-06-16 $17.14 60,600
2026-06-15 $17.16 92,500
2026-06-12 $16.95 100,200
2026-06-11 $16.86 139,100
2026-06-10 $16.51 88,200
2026-06-09 $16.78 166,100
2026-06-08 $16.67 69,500
2026-06-05 $16.92 127,000
2026-06-04 $17.27 63,600
2026-06-03 $16.93 130,800
2026-06-02 $17.18 146,200
2026-06-01 $17.60 99,500
2026-05-29 $17.86 64,900
2026-05-28 $17.67 118,600
2026-05-27 $17.53 67,100
2026-05-26 $17.37 94,500
About Abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

📰 Latest News
No news articles available at the moment. Check back later for updates on HQL.
Period:
Income Statement (Annual)
Metric 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Revenue
Total Revenue $86,385,919 $86,685,230 $23,523,699 $-103,250,433
Operating Revenue $86,385,919 $86,685,230 $23,523,699 $-103,250,433
Expenses
Operating Expense $791,573 $1,388,771 $1,171,451 $1,352,667
Other Operating Expenses $48,402 $56,656 $268,313 $275,967
General And Administrative Expense $743,171 $1,332,115 $903,138 $1,076,700
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $85,594,346 $85,296,459 $22,352,248 $-104,603,100
Net Interest Income $349,835 $1,043,143 $204,449 $50,092
Interest Income $349,835 $1,043,143 $204,449 $50,092
Normalized Income $85,594,346 $85,296,459 $22,352,248 $-104,603,100
Net Income From Continuing And Discontinued Operation $85,594,346 $85,296,459 $22,352,248 $-104,603,100
Net Income Common Stockholders $85,594,346 $85,296,459 $22,352,248 $-104,603,100
Net Income $85,594,346 $85,296,459 $22,352,248 $-104,603,100
Net Income Including Noncontrolling Interests $85,594,346 $85,296,459 $22,352,248 $-104,603,100
Net Income Continuous Operations $85,594,346 $85,296,459 $22,352,248 $-104,603,100
Pretax Income $85,594,346 $85,296,459 $22,352,248 $-104,603,100
Per Share
Diluted EPS - $3.04 $0.79 $-4.26
Basic EPS - $3.04 $0.79 $-4.26
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Diluted NI Availto Com Stockholders $85,594,346 $85,296,459 $22,352,248 $-104,603,100
Gain On Sale Of Security $27,893,949 $31,957,173 $35,886,276 $28,843,441
Selling General And Administration $743,171 $1,332,115 $903,138 $1,076,700
Diluted Average Shares - $28,058,046 $28,293,985 $24,554,718
Basic Average Shares - $28,058,046 $28,293,985 $24,554,718
Fetched: 2026-06-23
Balance Sheet (Annual)
Metric 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Assets
Net Tangible Assets $513,655,946 $459,694,606 $401,933,517 $397,902,357
Total Assets $515,382,001 $460,583,216 $402,600,476 $414,725,362
Investmentin Financial Assets $514,120,343 $460,301,419 $397,529,082 $414,076,080
Financial Assets Designatedas Fair Value Through Profitor Loss Total $505,702,990 $443,070,091 $397,529,082 $414,076,080
Prepaid Assets $38,862 $41,531 $26,090 $25,176
Receivables $1,138,099 $231,106 $5,044,638 $623,472
Taxes Receivable $8,970 $8,970 - -
Cash And Cash Equivalents $75,538 $1 $477 $445
Cash Financial $75,538 $1 $477 $445
Cash Cash Equivalents And Federal Funds Sold $75,538 $1 $477 $445
Liabilities
Total Liabilities Net Minority Interest $1,726,055 $888,610 $666,959 $16,823,005
Derivative Product Liabilities $434,456 $50,810 - -
Payables $1,169,297 $470,226 - $16,191,256
Other Payable $448,396 $468,435 - $11,091,542
Accounts Payable $720,901 $1,791 - $5,099,714
Equity
Common Stock Equity $513,655,946 $459,694,606 $401,933,517 $397,902,357
Total Equity Gross Minority Interest $513,655,946 $459,694,606 $401,933,517 $397,902,357
Stockholders Equity $513,655,946 $459,694,606 $401,933,517 $397,902,357
Retained Earnings $77,604,232 $44,128,491 $-1,481,234 $9,548,818
Other
Ordinary Shares Number $29,598,692 $28,061,399 $26,791,197 $25,679,636
Share Issued $29,598,692 $28,061,399 $26,791,197 $25,679,636
Tangible Book Value $513,655,946 $459,694,606 $401,933,517 $397,902,357
Additional Paid In Capital $435,755,727 $415,285,501 $403,146,839 $388,096,743
Capital Stock $295,987 $280,614 $267,912 $256,796
Common Stock $295,987 $280,614 $267,912 $256,796
Investments And Advances $514,120,343 $460,301,419 $397,529,082 $414,076,080
Available For Sale Securities $8,417,353 $17,231,328 - -
Fetched: 2026-06-23
Cash Flow Statement (Annual)
Metric 2025-09-30
Free Cash Flow
Free Cash Flow $31,708,543
Operating Activities
Operating Cash Flow $31,708,543
Financing Activities
Financing Cash Flow $-31,633,006
Net Other Financing Charges $0
Cash Dividends Paid $-31,633,006
Common Stock Dividend Paid $-31,633,006
Other
End Cash Position $75,538
Beginning Cash Position $1
Changes In Cash $75,537
Change In Working Capital $-262,642
Change In Other Current Liabilities $0
Change In Accrued Expense $-265,311
Change In Payable $0
Change In Prepaid Assets $2,669
Other Non Cash Items $59,233
Gain Loss On Investment Securities $-53,682,394
Net Income From Continuing Operations $85,594,346
Fetched: 2026-06-23